Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational
medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to
see if a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells
(ULSC) safe, tolerable, and feasible to administer.